A clinical trial to study the effect of two drugs , fentanyl , a drug used for pain relief and magnesium, another drug used for pain relief with bupivacaine , a drug used for providing anaesthesia in patients undergoing surgery on lower abdome
Phase 4
- Conditions
- Health Condition 1: - Health Condition 2: O- Medical and Surgical
- Registration Number
- CTRI/2022/09/045255
- Lead Sponsor
- Ankita Gupta
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
�Patient undergoing hysterectomygiving consent to participate in study
�Age between 18-60 years
ASA grade I and II
Exclusion Criteria
�Patients not giving consent to participate in the study.
�ASA grade III and IV
�Patients with respiratory, cardiovascular, hepatic and renal diseases, obesity and pregnancy.
�Age below <18 years and above >60 years.
�Any bleeding disorder and patient on anticoagulants.
�Neurological and musculoskeletal disease.
�Local infection at the injection site.
�Patient already receiving magnesium.
�Patient already receiving opioid agonist or antagonist in preceding 6 hrs of surgery
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Expected early onset of sensory and motor blockade with the addition of intrathecal fentanyl on comparison with magnesium . <br/ ><br>2.Expected prolonged duration of analgesia with the addition of intrathecal fentanyl. <br/ ><br>Timepoint: Intraoperative and postoperative <br/ ><br>
- Secondary Outcome Measures
Name Time Method 3.Expected stable haemodynamic profile and lesser side effects with intrathecal magnesium.Timepoint: Intraoperative and postoperative